Search

The histophagous ciliate Tetrahymena rostrata (Kahl, 1926) is a facultative parasite of the renal organ of land snails and slugs. The possibility of transovum transmission and the lack of heteroparental sex make T. rostrata an interesting model for studying host specificity and distribution patterns in pathogenic ciliates. We recorded mass Tetrahymena infection in the dusky slug (Arion fuscus (O.F. Muller, 1774)) collected in Slovakia, Central Europe. Based on the mitochondrial 16S rRNA gene and barcoding cytochrome c oxidase subunit I (COI) sequences, Slovak isolates belong to the TRO-1 subgroup. Strains of T. rostrata, however, do not cluster according to the relatedness of their gastropod hosts, i.e., various phylogenetically unrelated snails and slugs are parasitized by members of both T. rostrata subclades (TRO-1 and TRAUS). Invasion of adult gastropods through the integumentary pouch might be thus a more important transmission way than the transovum route. Geographic distances of T. rostrata isolates are not correlated with divergences in COI sequences. The absence of a clear relationship between genetic and geographic distances might have been, however, also caused by the human-mediated transmission of invasive gastropods. Key words: Tetrahymena rostrata, terrestrial gastropods, parasitology, nuclear rDNA cistron, mitochondrial 16S rRNA gene, cytochrome c oxidase subunit I, Introduction Tetrahymena rostrata (Kahl, 1926) Corliss, 1952 is a hymenostome ciliate that was first reported from mosses, leaf litter, and soil (e.g., Kahl 1926, 1931; Stout 1954; Corliss 1973). Subsequently, [...]

Background: Temporal lobe epilepsy (TLE), a prevalent chronic neurological disorder, affects millions of individuals and is often resistant to anti‐epileptic drugs. Increasing evidence has shown that acetylcholine (ACh) and cholinergic neurotransmission play a role in the pathophysiology of epilepsy. Tropisetron, an antiemetic drug used for chemotherapy in clinic, has displayed potential in the treatment of Alzheimer's disease, depression, and schizophrenia in animal models. However, as a partial agonist of α7 nicotinic acetylcholine receptors (α7nAChRs), whether tropisetron possesses the therapeutic potential for TLE has not yet been determined. Methods: In this study, tropisetron was intraperitoneally injected into pilocarpine‐induced epileptic rats for 3 weeks. Alpha‐bungarotoxin (α‐bgt), a specific α7nAChR antagonist, was applied to investigate the mechanism of tropisetron. Rats were assessed for spontaneous recurrent seizures (SRS) and cognitive function using video surveillance and Morris's water maze testing. Hippocampal impairment and synaptic structure were evaluated by Nissl staining, immunohistochemistry, and Golgi staining. Additionally, the levels of glutamate, γ‐aminobutyric acid (GABA), ACh, α7nAChRs, neuroinflammatory cytokines, glucocorticoids and their receptors, as well as synapse‐associated protein (F‐actin, cofilin‐1) were quantified. Results: The results showed that tropisetron significantly reduced SRS, improved cognitive function, alleviated hippocampal sclerosis, and concurrently suppressed synaptic remodeling and the m6A modification of cofilin‐1 in TLE rats. Furthermore, tropisetron lowered glutamate levels without affecting GABA levels, reduced neuroinflammation, and increased ACh levels and α7nAChR expression in the hippocampi of TLE rats. The effects of tropisetron treatment were counteracted by α‐bgt. Conclusion: In summary, these findings indicate that tropisetron exhibits an anti‐epileptic effect and provides neuroprotection in TLE rats through the activation of α7nAChRs. The potential mechanism may involve the reduction of glutamate levels, enhancement of cholinergic transmission, and suppression of synaptic remodeling. Consequently, the present study not only highlights the potential of tropisetron as an anti‐epileptic drug but also identifies α7nAChRs as a promising therapeutic target for the treatment of TLE. [ABSTRACT FROM AUTHOR]

Lymphangioleiomyomatosis (LAM) is a rare, multisystemic, low-grade neoplasm character-ized by diffuse cystic lesions in the lung.In recent years, emerging imaging examination such as 68Ga-NEB PET-CT scan provides efficient and precise non-invasive diagnostic methods to detect lymphatic circulation abnormalities in LAM patients. The long-term efficacy and safety of sirolimus for LAM has accumulated further evidence, and genetic profiling studies have unveiled more information of genetic mechanisms. Prognosis of LAM has been much improved. We briefly reviewed the research advances of LAM in China and other countires.